Study on Safety, Tolerability & Immunogenicity of an MVA Vaccine

See also
Status	Clinical Trial	Phase
Completed	`NCT05976100` - Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years	Phase 1
Completed	`NCT01540929` - Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel
Completed	`NCT00258947` - Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults	Phase 2
Completed	`NCT00189969` - Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects	Phase 1
Terminated	`NCT00053508` - Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination	Phase 2
Completed	`NCT01317238` - Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers	Phase 3
Completed	`NCT01056770` - Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers	Phase 3
Terminated	`NCT00282581` - Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive	Phase 1
Completed	`NCT00998543` - A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)	Phase 2
Withdrawn	`NCT00389103` - Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)	Phase 1
Completed	`NCT00133575` - ACAM 3000 MVA at Harvard Medical School	Phase 1/Phase 2
Active, not recruiting	`NCT00103584` - Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers	Phase 1/Phase 2
Completed	`NCT00050505` - Expanded Dryvax Dilution Study in Previously Vaccinated Adults	Phase 2
Completed	`NCT05846243` - Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years	Phase 2/Phase 3
Completed	`NCT05935917` - Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults	Phase 1
Completed	`NCT00082446` - Combination Study With MVA BN and Dryvax	Phase 1
Completed	`NCT00038987` - Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT	Phase 1/Phase 2
Completed	`NCT05762523` - Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years	Phase 1
Completed	`NCT04971109` - Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Day	Phase 3
Completed	`NCT00646152` - Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study	Phase 1

NCT number	NCT00189943
Study type	Interventional
Source	Bavarian Nordic
Contact
Status	Completed
Phase	Phase 1
Start date	April 2001
Completion date	July 2003

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms